213 related articles for article (PubMed ID: 27279145)
1. Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
Int J Oncol; 2016 Aug; 49(2):539-48. PubMed ID: 27279145
[TBL] [Abstract][Full Text] [Related]
2. PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex.
Gong X; Tang H; Yang K
Cell Death Dis; 2021 Mar; 12(3):276. PubMed ID: 33723221
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
Wang Q; Zhang X; Song X; Zhang L
Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
[TBL] [Abstract][Full Text] [Related]
4. Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells.
Li J; Guo Y; Feng X; Wang Z; Wang Y; Deng P; Zhang D; Wang R; Xie L; Xu X; Zhou Y; Ji N; Hu J; Zhou M; Liao G; Geng N; Jiang L; Wang Z; Chen Q
J Cancer Res Clin Oncol; 2012 Apr; 138(4):563-71. PubMed ID: 22207523
[TBL] [Abstract][Full Text] [Related]
5. CircRNA_002178 promotes the proliferation and migration of oral squamous cell carcinoma cells by activating the Akt/mTOR pathway.
Yang Y; Ci HS; Mao YL; Li JW; Zuo JH
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6122-6130. PubMed ID: 32572877
[TBL] [Abstract][Full Text] [Related]
6. AZD2014 Radiosensitizes Oral Squamous Cell Carcinoma by Inhibiting AKT/mTOR Axis and Inducing G1/G2/M Cell Cycle Arrest.
Yu CC; Huang HB; Hung SK; Liao HF; Lee CC; Lin HY; Li SC; Ho HC; Hung CL; Su YC
PLoS One; 2016; 11(3):e0151942. PubMed ID: 27031247
[TBL] [Abstract][Full Text] [Related]
7. Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation.
Jiang X; Wang J; Chen X; Hong Y; Wu T; Chen X; Xia J; Cheng B
Oncotarget; 2016 Mar; 7(13):16262-72. PubMed ID: 26919103
[TBL] [Abstract][Full Text] [Related]
8. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.
Yang G; Yang Y; Tang H; Yang K
Cancer Sci; 2020 May; 111(5):1542-1554. PubMed ID: 32086839
[TBL] [Abstract][Full Text] [Related]
9. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma.
Yang Y; Chen D; Liu H; Yang K
Cell Death Dis; 2019 Jan; 10(2):41. PubMed ID: 30674868
[TBL] [Abstract][Full Text] [Related]
11. Loss of RACK1 promotes glutamine addiction via activating AKT/mTOR/ASCT2 axis to facilitate tumor growth in gastric cancer.
Chen M; Wang G; Xu Z; Sun J; Liu B; Chang L; Gu J; Ruan Y; Gao X; Song S
Cell Oncol (Dordr); 2024 Feb; 47(1):113-128. PubMed ID: 37578594
[TBL] [Abstract][Full Text] [Related]
12. The Akt/mTOR pathway is activated in verrucous carcinoma of the oral cavity.
Chaisuparat R; Limpiwatana S; Kongpanitkul S; Yodsanga S; Jham BC
J Oral Pathol Med; 2016 Sep; 45(8):581-5. PubMed ID: 26775690
[TBL] [Abstract][Full Text] [Related]
13. RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-κB pathway in oral squamous cell carcinoma.
Dan H; Liu S; Liu J; Liu D; Yin F; Wei Z; Wang J; Zhou Y; Jiang L; Ji N; Zeng X; Li J; Chen Q
Mol Oncol; 2020 Apr; 14(4):795-807. PubMed ID: 31997535
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway.
Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y
J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143
[TBL] [Abstract][Full Text] [Related]
15. [Expression of RACK1 and EGP40 in oral squamous cell carcinoma and its correlation with clinicopathological features and prognosis].
Duan YH; Wu KL; Mei J; Zhou YY; Liu MS
Shanghai Kou Qiang Yi Xue; 2023 Aug; 32(4):385-390. PubMed ID: 38044732
[TBL] [Abstract][Full Text] [Related]
16. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
[TBL] [Abstract][Full Text] [Related]
17. Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling.
Xu L; Li J; Tursun M; Hai Y; Tursun H; Mamtimin B; Hasim A
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35616137
[TBL] [Abstract][Full Text] [Related]
18. CCN5 inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells.
Sun S; Cui Z; Yan T; Wu J; Liu Z
Cell Biol Int; 2020 Apr; 44(4):998-1008. PubMed ID: 31889370
[TBL] [Abstract][Full Text] [Related]
19. RACK1 is an organ-specific prognostic predictor in OSCC.
Liu S; Liu J; Wang J; Cheng J; Zeng X; Ji N; Li J; Chen Q
Oral Oncol; 2018 Jan; 76():22-26. PubMed ID: 29290282
[TBL] [Abstract][Full Text] [Related]
20. OTUB1's role in promoting OSCC development by stabilizing RACK1 involves cell proliferation, migration, invasion, and tumor-associated macrophage M1 polarization.
Li Y; Li R; Qin H; He H; Li S
Cell Signal; 2023 Oct; 110():110835. PubMed ID: 37532135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]